An Israeli pharmaceutical company will soon begin testing its COVID-19 vaccine pill on humans.
Oramed Pharmaceuticals Inc. announced today that its subsidiary Oravax received permission from South African authorities to begin the first phase of the oral vaccine’s trial. Oramed can begin enrolling patients for the trial and is currently preparing to actually begin administering the pill, according to the Jerusalem-based firm’s statement.
